Unique combination and in silico modeling of biallelic POLR3A variants as a cause of Wiedemann-Rautenstrauch syndrome.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
12 2020
Historique:
received: 28 11 2019
accepted: 02 06 2020
revised: 19 05 2020
pubmed: 20 6 2020
medline: 3 6 2021
entrez: 20 6 2020
Statut: ppublish

Résumé

Neonatal progeroid syndrome or Wiedemann-Rautenstrauch syndrome (WRS; MIM 264090) is a rare genetic disorder that has clinical symptoms including premature aging, lipodystrophy, and variable mental impairment. Until recently genetic background of the disease was unclear. However, recent studies have indicated that WRS patients have compound heterozygote variations in the POLR3A (RNA polymerase III subunit 3A; MIM 614258) gene that might be responsible for the disease phenotype. In this study we report a WRS patient that has compound heterozygote variations in the POLR3A gene. One of the reported variations in our patient, c.3568C>T, p.(Gln1190Ter), is a novel variation that was not reported before. The other variant, c.3337-11T>C, was previously shown in WRS patients in trans with other variations.

Identifiants

pubmed: 32555393
doi: 10.1038/s41431-020-0673-1
pii: 10.1038/s41431-020-0673-1
pmc: PMC7784914
doi:

Substances chimiques

POLR3A protein, human EC 2.7.7.6
RNA Polymerase III EC 2.7.7.6

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1675-1680

Références

Arboleda G, Morales LC, Quintero L, Arboleda H. Neonatal progeroid syndrome (Wiedemann–Rautenstrauch syndrome): report of three affected sibs. Am J Med Genet A. 2011;155a:1712–5.
doi: 10.1002/ajmg.a.34019
Arboleda G, Ramirez N, Arboleda H. The neonatal progeroid syndrome (Wiedemann–Rautenstrauch): a model for the study of human aging?. Exp Gerontol. 2007;42:939–43.
doi: 10.1016/j.exger.2007.07.004
Akawi N, Ali B, Al Gazali L. A progeroid syndrome with neonatal presentation and long survival maps to 19p13.3p13.2. Birth Defects Res A Clin Mol Teratol. 2013;97:456–62.
doi: 10.1002/bdra.23136
Wambach JA, Wegner DJ, Patni N, Kircher M, Willing MC, Baldridge D, et al. Bi-allelic POLR3A loss-of-function variants cause autosomal-recessive Wiedemann–Rautenstrauch syndrome. Am J Hum Genet. 2018;103:968–75.
doi: 10.1016/j.ajhg.2018.10.010
Bernard G, Vanderver A. POLR3-Related Leukodystrophy. 2012 Aug 2 [Updated 2017 May 11]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK99167 .
Bernard G, Chouery E, Putorti ML, Tetreault M, Takanohashi A, Carosso G, et al. Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am J Hum Genet. 2011;89:415–23.
doi: 10.1016/j.ajhg.2011.07.014
Paolacci S, Bertola D, Franco J, Mohammed S, Tartaglia M, Wollnik B, et al. Wiedemann–Rautenstrauch syndrome: a phenotype analysis. Am J Med Genet A. 2017;173:1763–72.
doi: 10.1002/ajmg.a.38246
Jay AM, Conway RL, Thiffault I, Saunders C, Farrow E, Adams J, et al. Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A. Am J Med Genet A. 2016;170:3343–6.
doi: 10.1002/ajmg.a.37960
Lessel D, Ozel AB, Campbell SE, Saadi A, Arlt MF, McSweeney KM, et al. Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann–Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations. Hum Genet. 2018;137:921–39.
doi: 10.1007/s00439-018-1957-1
Minnerop M, Kurzwelly D, Wagner H, Soehn AS, Reichbauer J, Tao F, et al. Hypomorphic mutations in POLR3A are a frequent cause of sporadic and recessive spastic ataxia. Brain. 2017;140:1561–78.
doi: 10.1093/brain/awx095
Gauquelin L, Tetreault M, Thiffault I, Farrow E, Miller N, Yoo B, et al. POLR3A variants in hereditary spastic paraplegia and ataxia. Brain. 2018;141:e1.
doi: 10.1093/brain/awx290
Minnerop M, Kurzwelly D, Rattay TW, Timmann D, Hengel H, Synofzik M, et al. Reply: POLR3A variants in hereditary spastic paraplegia and ataxia. Brain. 2018;141:e2.
doi: 10.1093/brain/awx291
Báez-Becerra CT, Valencia-Rincón E, Velásquez-Méndez K, Ramírez-Suárez N, Guevara C, Sandoval-Hernandez A, et al. Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann–Rautenstrauch syndrome fibroblasts. BioRxiv. 2020. https://www.biorxiv.org/content/10.1101/2020.01.29.925131v1.full .
Marceddu G, Dallavilla T, Guerri G, Manara E, Chiurazzi P, Bertelli M, et al. PipeMAGI: an integrated and validated workflow for analysis of NGS data for clinical diagnostics. Eur Rev Med Pharmacol Sci. 2019;23:6753–65.
pubmed: 31378919
Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet. 2017;136:665–77.
doi: 10.1007/s00439-017-1779-6
Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40:W452–7.
doi: 10.1093/nar/gks539
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.
doi: 10.1038/nmeth0410-248
Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361–2.
doi: 10.1038/nmeth.2890
Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 2011;39:e118.
doi: 10.1093/nar/gkr407
Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Bioinform. 2016;54:5.6.1–37.
doi: 10.1002/cpbi.3
Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct. 2000;29:291–325.
doi: 10.1146/annurev.biophys.29.1.291
Ding Z, Kihara D. Computational methods for predicting protein-protein interactions using various protein features. Curr Protoc Protein Sci. 2018;93:e62.
doi: 10.1002/cpps.62
DeLano WL. The PyMOL molecular graphics system. 2008. http://pymol.org .
Paolacci S, Li Y, Agolini E, Bellacchio E, Arboleda-Bustos CE, Carrero D, et al. Specific combinations of biallelic POLR3A variants cause Wiedemann–Rautenstrauch syndrome. J Med Genet. 2018;55:837–46.
doi: 10.1136/jmedgenet-2018-105528
Dauwerse JG, Dixon J, Seland S, Ruivenkamp CA, van Haeringen A, Hoefsloot LH, et al. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet. 2011;43:20–2.
doi: 10.1038/ng.724

Auteurs

Sehime Gulsun Temel (SG)

Bursa Uludag University, Faculty of Medicine, Department of Medical Genetics, Bursa, Turkey. sehime@uludag.edu.tr.
Bursa Uludag University, Faculty of Medicine, Department of Histology and Embryology, Bursa, Turkey. sehime@uludag.edu.tr.
Bursa Uludag University, Institute of Health Sciences, Department of Translational Medicine, Bursa, Turkey. sehime@uludag.edu.tr.

Mahmut Cerkez Ergoren (MC)

Near East University, Faculty of Medicine, Department of Medical Biology, 99138, Nicosia, Cyprus.
Near East University, DESAM Insitute, 99138, Nicosia, Cyprus.

Elena Manara (E)

MAGI Euregio, Bolzano, Italy.

Gulten Tuncel (G)

Near East University, Faculty of Medicine, Department of Medical Biology, 99138, Nicosia, Cyprus.
Near East University, DESAM Insitute, 99138, Nicosia, Cyprus.

Seref Gul (S)

Koc University, Faculty of Engineering, Department of Chemical and Biological Engineering, Istanbul, Turkey.

Matteo Bertelli (M)

MAGI's LAB S.r.l., Rovereto, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH